Renowned Proteomics Researcher Dr. Ruedi Aebersold to Speak at 38th Annual EMD Millipore-UCSD Lectureship Series

Share Article

• Dr. Aebersold is a pioneer in quantitative proteomics and systems biology. • Two different lectures will be held on consecutive nights. • The public and press are welcome to attend by registering at

EMD Millipore, the Life Science division of Merck KGaA* of Germany, is proud to sponsor a lecture series featuring world-renowned proteomics researcher Dr. Reudi Aebersold. The series includes two lectures: “Quantitative Proteomics and Systems Biology” on April 12, 2011, and “Mass Spectrometric Methods to Measure Dynamic Protein Interaction Networks” on April 13, 2011. Both lectures begin at 4:00 p.m. in the Health Sciences Education Center Auditorium, Skaggs School of Pharmacy, University of California, San Diego (UCSD).

Dr. Aebersold is Professor, Molecular Systems Biology at ETH Zurich. His research focuses on developing new methods and technologies for quantitative proteomics, and on applying this emerging technology to enhance our understanding of the structure, function, and control of complex biological systems. Current applications of quantitative proteomics technology are directed to the discovery of protein markers that differentiate cancer cells from their normal counterparts, to the investigation of the mechanisms of fundamental cellular processes by the comparative analysis of the gene and protein expression profiles in cells at different states, and to systems biology studies.

The work of Dr. Aebersold’s group has been recognized by numerous awards, most recently the Otto Naegeli Prize in Switzerland, the Herbert Sober award by ASBMB, the FEBS Buchner medal and the ASMS Bieman Award.

This lectureship series continues a 38-year partnership between EMD Millipore (formerly EMD Chemicals and Calbiochem®) and UCSD in support of the life science research community. EMD Millipore’s Calbiochem portfolio of research reagents, which is well known among researchers studying disease states and signal transduction, includes enzyme inhibitors, biochemicals, proteins, application-tested antibodies and assay kits.

The public and press are welcome to attend by registering at:

About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science. Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 64 countries and pro forma 2009 revenues of $2.9 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.

Millipore is a registered trademark of Millipore Corporation. The M logo is a trademark of Merck KGaA. EMD and Calbiochem are registered trademarks of Merck KGaA.

*Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Greg Hoff

+1 978 762 5170
Email >